Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01258634 Background | Jul 2010 → Nov 2011 | osteosarcoma, respiratory system cancer | University of Chicago | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01258634 ↗ |
| Route | Intravenous | “5mcg/Kg; IV/SQ starting 24 hours after chemotherapy” NCT01258634 ↗ |
| Route | Subcutaneous | “5mcg/Kg; IV/SQ starting 24 hours after chemotherapy” NCT01258634 ↗ |